PHARMACOLOGY FOR CANADIAN HEALTH CARE PRACTICE 3RD EDITION LILLEY TEST BANK – NUR 210 COMPLETE CHAPTERS 1-58 WITH RATIONALES

PREMIUM CANADIAN PHARMACOLOGY TEST BANK – YOUR COMPLETE GUIDE TO SAFE AND EFFECTIVE DRUG THERAPY! This comprehensive test bank provides practice questions with detailed answers and rationales for all 58 chapters, covering the entire scope of pharmacology for Canadian nursing practice. Based on the trusted Lilley textbook, this is your essential companion for mastering core drug concepts, acing your exams, and ensuring safe medication administration in any healthcare setting. Why This Test Bank? 58 Chapters Covered – Per Table of Contents (Ch. 1-58) Multiple Questions Per Chapter – Extensive practice with varied question types (Multiple Choice, Multiple Response, Matching) Detailed Answers – Every answer verified and provided for all questions Comprehensive Coverage – All core topics from pharmacologic principles to specific drug classes Canadian Focus – Content tailored to Canadian health care practice, regulations, and standards Searchable PDF – Find topics instantly Mobile-Ready – Study on any device, anytime Latest 3rd Canadian Edition – The most current content for your Pharmacology course Chapter Highlights: Ch. 1: Nursing Practice in Canada and Drug Therapy – Nursing process, rights of medication administration, outcome criteria Ch. 2: Pharmacological Principles – Absorption, distribution, metabolism, excretion (ADME), half-life, onset, peak, duration, drug interactions Ch. 3: Legal and Ethical Considerations – Canadian drug legislation (Food and Drugs Act, Controlled Drugs and Substances Act), schedules, informed consent, drug polymorphism Ch. 4: Patient Focused Considerations – Pediatrics, pregnancy (FDA categories), older adults, polypharmacy, cultural considerations, Indigenous health Ch. 5: Gene Therapy and Pharmacogenomics – DNA, Human Genome Project, genetic testing, cytochrome P450 enzymes, ethical issues (eugenics) Ch. 6: Medication Errors: Preventing and Responding – Types of errors, ISMP Canada, safe medication practices, error prevention strategies Ch. 7: Patient Education and Drug Therapy – Learning domains (cognitive, affective, psychomotor), nursing diagnoses, developmental considerations Ch. 8: Over-the-Counter Drugs and Natural Health Products – Regulations (NHPD), herb-drug interactions (St. John's wort, kava, garlic), safety concerns Ch. 9: Vitamins and Minerals – Fat-soluble vs. water-soluble vitamins, deficiencies, toxicities, calcium, iron, vitamin D in Canada Ch. 10: Principles of Drug Administration – Routes (PO, IM, IV, sublingual, buccal, topical), injection sites, Z-track, nasogastric, inhalers Ch. 11: Analgesic Drugs – Opioids (morphine, codeine), non-opioids (acetaminophen, NSAIDs), opioid antagonists (naloxone), patient-controlled analgesia (PCA) Ch. 12: General and Local Anaesthetics – Stages of anaesthesia, neuromuscular blockers (NMBAs), malignant hyperthermia, procedural sedation Ch. 13: Central Nervous System Depressants and Muscle Relaxants – Barbiturates, benzodiazepines, flumazenil, sleep hygiene, muscle relaxants Ch. 14: Central Nervous System Stimulants and Related Drugs – Amphetamines, caffeine, anorexiants, methylphenidate (Ritalin), modafinil, orlistat Ch. 15: Antiepileptic Drugs – Seizure types, phenytoin, carbamazepine, valproic acid, therapeutic drug monitoring, status epilepticus Ch. 16: Antiparkinsonian Drugs – Levodopa/carbidopa, dopamine agonists, COMT inhibitors, anticholinergics, "on-off" phenomenon Ch. 17: Psychotherapeutic Drugs – Antidepressants (SSRIs, SNRIs, TCAs, MAOIs), antipsychotics, lithium, anxiolytics (buspirone), serotonin syndrome Ch. 18: Substance Misuse – Alcohol withdrawal, disulfiram (Antabuse), opioid addiction (methadone, naltrexone), nicotine replacement therapy Ch. 19: Adrenergic Drugs – Sympathomimetics, alpha and beta receptors, epinephrine, dopamine, dobutamine, adverse effects, anaphylaxis treatment Ch. 20: Adrenergic-Blocking Drugs – Alpha-blockers (prazosin), beta-blockers (metoprolol), pheochromocytoma, orthostatic hypotension, rebound hypertension Ch. 21: Cholinergic Drugs – Direct-acting (pilocarpine), indirect-acting (physostigmine), myasthenia gravis, cholinergic crisis, Alzheimer's treatment (donepezil) Ch. 22: Cholinergic-Blocking Drugs – Anticholinergics (atropine), scopolamine, oxybutynin, anticholinergic toxicity, heat stroke risk in older adults Ch. 23: Antihypertensive Drugs – ACE inhibitors, ARBs, calcium channel blockers, diuretics, patient teaching, African-Canadian considerations, hypertensive crisis Ch. 24: Antianginal Drugs – Nitrates (nitroglycerin), beta-blockers, calcium channel blockers, angina types, tolerance prevention, sublingual administration Ch. 25: Heart Failure Drugs – Cardiac glycosides (digoxin), inotropes (milrinone), diuretics, digoxin toxicity, monitoring, antidote (digoxin immune Fab) Ch. 26: Antidysrhythmic Drugs – Vaughan Williams classification, amiodarone, lidocaine, adenosine, adverse effects, monitoring Ch. 27: Coagulation Modifier Drugs – Anticoagulants (heparin, warfarin), antiplatelets (ASA, clopidogrel), thrombolytics, antidotes (protamine, vitamin K) Ch. 28: Antilipemic Drugs – Statins, bile acid sequestrants, fibrates, niacin, ezetimibe, monitoring (liver function, muscle pain), grapefruit juice interaction Ch. 29: Diuretic Drugs – Loop (furosemide), thiazide (HCTZ), potassium-sparing (spironolactone), osmotic (mannitol), electrolyte imbalances, ototoxicity Ch. 30: Fluids and Electrolytes – IV fluids, blood products (PRBCs, FFP), electrolyte replacement (potassium, sodium), transfusion reactions Ch. 31: Pituitary Drugs – Posterior pituitary (vasopressin, desmopressin), anterior pituitary (somatropin), diabetes insipidus, SIADH Ch. 32: Thyroid and Antithyroid Drugs – Levothyroxine, methimazole, propylthiouracil, radioactive iodine, myxedema, thyrotoxic crisis Ch. 33: Antidiabetic Drugs – Insulin types (rapid, short, intermediate, long), oral agents (sulfonylureas, metformin, DPP-4 inhibitors), hypoglycemia, sick day rules Ch. 34: Adrenal Drugs – Corticosteroids (prednisone), mineralocorticoids (fludrocortisone), Cushing's syndrome, adrenal insufficiency, withdrawal Ch. 35: Women's Health Drugs – Estrogens, progestins, oral contraceptives, HRT, SERMs (raloxifene), bisphosphonates (alendronate), oxytocin Ch. 36: Men's Health Drugs – Androgens, PDE5 inhibitors (sildenafil), finasteride (Proscar), saw palmetto, priapism, prostate cancer considerations Ch. 37: Antihistamines, Decongestants, Antitussives, and Expectorants – First vs. second-generation antihistamines, pseudoephedrine, dextromethorphan, guaifenesin Ch. 38: Respiratory Drugs – Bronchodilators (beta-agonists, xanthines), corticosteroids, antileukotrienes (montelukast), inhaler technique, spacer use Ch. 39: Acid-Controlling Drugs – Antacids, H2 blockers (cimetidine, ranitidine), PPIs (omeprazole), misoprostol, H. pylori treatment Ch. 40: Antidiarrheal Drugs and Laxatives – Opioid antidiarrheals (loperamide), adsorbents (bismuth), bulk-forming, stimulant, osmotic laxatives, dependency Ch. 41: Antiemetic and Anti-nausea Drugs – Serotonin blockers (ondansetron), antihistamines (meclizine), anticholinergics (scopolamine), prokinetics (metoclopramide) Ch. 42: Nutritional Supplements – Enteral nutrition, TPN, complications (refeeding syndrome, hyperglycemia), monitoring Ch. 43: Antibiotics, Part 1: Sulfonamides, Penicillins, Cephalosporins, Macrolides, and Tetracyclines – Mechanisms, spectrum, cross-allergy, superinfection, drug interactions Ch. 44: Antibiotics Part 2: Aminoglycosides, Fluoroquinolones, and Other Drugs – Ototoxicity, nephrotoxicity, vancomycin (red man syndrome), metronidazole Ch. 45: Antiviral Drugs – Acyclovir, influenza antivirals (oseltamivir), antiretrovirals (HAART), HIV treatment, adverse effects, resistance Ch. 46: Antitubercular Drugs – Isoniazid, rifampin, ethambutol, pyrazinamide, multidrug therapy, hepatotoxicity, peripheral neuropathy (B6) Ch. 47: Antifungal Drugs – Amphotericin B, azoles (fluconazole), terbinafine, nystatin, monitoring (renal function, electrolytes) Ch. 48: Antimalarial, Antiprotozoal, and Anthelmintic Drugs – Chloroquine, mefloquine, metronidazole, praziquantel, prophylaxis Ch. 49: Anti-Inflammatory and Antigout Drugs – NSAIDs, COX-2 inhibitors, colchicine, allopurinol, probenecid, salicylate toxicity Ch. 50: Immunosuppressant Drugs – Cyclosporine, tacrolimus, sirolimus, azathioprine, mycophenolate, transplant rejection, monitoring Ch. 51: Immunizing Drugs and Pandemic Preparedness – Vaccines (MMR, DTaP, HPV), immunoglobulins, active vs. passive immunity, contraindications Ch. 52: Antineoplastic Drugs Part 1: Cancer Overview and Cell Cycle–Specific Drugs – Chemotherapy principles, nadir, extravasation, stomatitis, nadir Ch. 53: Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific and Miscellaneous Drugs – Alkylating agents, antitumor antibiotics, hormonal agents, targeted therapy (imatinib) Ch. 54: Biological Response–Modifying Drugs – Interferons, interleukins, colony-stimulating factors (epoetin alfa, filgrastim), monoclonal antibodies Ch. 55: Anemia Drugs – Iron preparations (ferrous sulfate), folic acid, vitamin B12, iron dextran (Z-track), patient teaching Ch. 56: Dermatological Drugs – Topical corticosteroids, antifungals, antibacterials (mupirocin), antivirals (acyclovir), acne treatments (tretinoin, isotretinoin) Ch. 57: Ophthalmic Drugs – Glaucoma medications (beta-blockers, miotics), anti-infectives, anti-inflammatories, diagnostic agents (fluorescein), administration technique Ch. 58: Otic Drugs – Antibiotic/anti-inflammatory combinations, cerumenolytics (carbamide peroxide), administration technique, contraindications (perforated eardrum) Key Topics Covered: Canadian drug legislation and schedules (Controlled Drugs and Substances Act) Nursing process and medication administration Pharmacokinetics and pharmacodynamics Pediatric, geriatric, and pregnancy considerations Natural health products and herb-drug interactions Pain management and opioid safety Cardiovascular drugs (antihypertensives, antianginals, heart failure, antidysrhythmics) Coagulation modifiers and antiplatelet therapy Endocrine drugs (diabetes, thyroid, adrenal) Psychotherapeutic drugs and substance misuse Antibiotics, antivirals, antifungals, and antituberculars Antineoplastics and biological response modifiers Fluid, electrolyte, and nutritional therapy Ophthalmic, otic, and dermatological drugs Perfect For: NUR 210, PHAR 200, PN 105, LPN 105, VN 105, NUR 310 + NCLEX-PN/RN Pharmacology Prep ⏳ MASTER CANADIAN PHARMACOLOGY TODAY – DOWNLOAD INSTANTLY ON STUVIA AND ADMINISTER MEDICATIONS WITH CONFIDENCE AND SAFETY!